Latest News and Press Releases

- EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample...

- La EMA ha dado su aprobación global al ensayo clínico de fase III propuesto para VCN-01 en combinación con gemcitabina/nab-paclitaxel para el tratamiento de primera línea del ACDP metastásico,...

MINNEAPOLIS, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,...

NESS ZIONA, Israel, Dec. 29, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies...

HOUSTON, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the “Company” or “Orion”), a leading specialty construction company, today announced that it has entered into a...

HAMILTON, BERMUDA, December 29, 2025 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announces that it has entered into an agreement to sell the DHT China and the DHT Europe for a...

CHANTILLY, Va., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Today, Parsons Corporation (NYSE: PSN) is once again saluting military veterans, guard and reserve members, and their families, as the company...

Transaction in Own Shares

NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund’s monthly...

RAMAT GAN, Israel, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs...